Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China

OBJECTIVE: We aimed to clarify the efficacy of dapagliflozin versus liraglutide in patients with overweight or obesity and type 2 diabetes mellitus (T2DM) at the beginning of the coronavirus disease 2019 (COVID-19) pandemic. METHODS: T2DM patients with overweight or obesity who visited the Metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhaohu, Hao, Xiao, Huang, Hailin, Shao, Feng, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381852/
https://www.ncbi.nlm.nih.gov/pubmed/35990242
http://dx.doi.org/10.1155/2022/4126995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381852/
https://www.ncbi.nlm.nih.gov/pubmed/35990242
http://dx.doi.org/10.1155/2022/4126995

Ejemplares similares